Radioiodine therapy in patients with low-thyroid cancer
Horácek, Jí.
Vnitrni Lekarstvi 61(9): 755-757
2015
ISSN/ISBN: 0042-773X PMID: 26790168 Document Number: 684849
Document emailed within 1 workday
Related Documents
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307
Grudeva-Popova, J.; Yaneva, M.; Zisov, K.; Ananoshtev, N. 2007: Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 129-132
Bednár, J.; Nĕmec, J.; Soutorová, M.; Neradilová, M.; Pohunková, D.; Zamrazil, V.; Vána, S.; Havelka, J.; Röhling, S. 1979: Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment Endocrinologia Experimentalis 13(1): 53-63
Ursu, H.I.; Dumitriu, L.; Grigorie, D.; Simescu, M.; Vaida, E.; Belgun, M.; Popovici, D. 1993: Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease) Romanian Journal of Endocrinology 31(3-4): 155-163
Sriprapaporn, J.; Sethanandha, C.; Yingsa-nga, T.; Komoltri, C.; Thongpraparn, T.; Harnnanthawiwai, C. 2015: Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer Journal of the Medical Association of Thailand 98(6): 596-605
Zakani, A.; Saghari, M.; Eftekhari, M.; Fard-Esfahani, A.; Fallahi, B.; Esmaili, J.; Assadi, M. 2011: Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131i with emphasize on the thallium scintigraphy in these subgroups European Review for Medical and Pharmacological Sciences 15(10): 1215-1221
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Bałdys-Waligórska, A.; Gołkowski, F.; Krzentowska-Korek, A.; Hubalewska-Dydejczyk, A. 2010: Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal Endokrynologia Polska 61(5): 474-479
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238
Dirr, W.; Pabst, H.W. 1982: Treatment of follicular thyroid cancer with radioiodine Schweizerische Rundschau für Medizin Praxis 71(13): 562-566
Roldán Schilling, V.; Fernández Abellán, P.; Domínguez Escribano, J.R.; Rivas González, C.; Mut Barberá, E.; Calatayud Cendra, R. 1998: Acute leukemias after treatment with radioiodine for thyroid cancer Haematologica 83(8): 767-768
Hodak, S.P.; Carty, S.E. 2009: Radioiodine-resistant differentiated thyroid cancer: hope for the future Oncology 23(9): 775-776
Saengsuda, Y. 2013: Radioiodine remnant ablation in low-risk differentiated thyroid cancer Journal of the Medical Association of Thailand 96(5): 614-624
Claimon, A.; Pusuwan, P.; Khiewvan, B. 2017: Factors Influencing the Success of the first Radioiodine Therapy for Differentiated Thyroid Carcinoma Journal of the Medical Association of Thailand 100(2): 207-218
Krohn, T.; Meyer, P.T.; Ocklenburg, C.; Knollmann, D.; Nowak, B.; Schaefer, W.M. 2008: Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance NUKLEARMEDIZIN. Nuclear Medicine 47(6): 248-254
Dunkelmann, S.; Rudolph, F.; Prillwitz, A.; Groth, P.; Schümichen, C. 1998: Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy NUKLEARMEDIZIN. Nuclear Medicine 37(1): 23-29
Schober, O.; Günter, H.H.; Schwarzrock, R.; Hundeshagen, H. 1987: Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 163(7): 464-474
Sumimura, J.; Nakagawa, K.; Kawamura, J.; Tayama, M.; Takahashi, E.; Moritomo, T.; Miyata, M. 1990: Thyroid cancer metastasis to the lumbar spine successfully treated by embolization and radioiodine. A case report Nihon Geka Gakkai Zasshi 91(7): 910-913
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450